US Stock MarketDetailed Quotes

Integra Lifesciences (IART)

Watchlist
  • 13.920
  • +0.360+2.65%
Close May 8 15:59 ET
  • 13.920
  • 0.0000.00%
Post 20:01 ET
1.08BMarket Cap-2.15P/E (TTM)

Integra Lifesciences (IART) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
2.42%391.92M
1.53%1.64B
-1.74%434.93M
5.57%402.06M
-0.61%415.61M
3.74%382.65M
4.47%1.61B
11.49%442.65M
-0.41%380.83M
9.68%418.18M
Operating revenue
2.42%391.92M
1.53%1.64B
-1.74%434.93M
5.57%402.06M
-0.61%415.61M
3.74%382.65M
4.47%1.61B
11.49%442.65M
-0.41%380.83M
9.68%418.18M
Cost of revenue
-7.06%174.94M
10.32%803.63M
10.58%214.06M
8.02%195.07M
7.29%206.27M
16.16%188.22M
10.90%728.47M
13.50%193.57M
10.07%180.6M
10.34%192.26M
Gross profit
11.60%216.98M
-5.72%831.62M
-11.32%220.87M
3.37%206.99M
-7.34%209.33M
-6.00%194.43M
-0.30%882.06M
9.97%249.07M
-8.29%200.24M
9.12%225.92M
Operating expense
-2.10%205.51M
-4.69%813.63M
-7.32%197.83M
-6.31%195.23M
-8.00%210.64M
3.48%209.93M
10.40%853.65M
12.08%213.45M
8.68%208.39M
17.70%228.95M
Selling and administrative expenses
-1.80%178.24M
-2.41%699.7M
-5.18%169.27M
-4.60%169.05M
-7.97%179.89M
9.47%181.5M
9.19%716.98M
9.44%178.52M
9.41%177.19M
18.53%195.47M
Research and development costs
-4.96%23.5M
-14.22%98.97M
-20.57%24.79M
-18.15%22.46M
-9.31%27M
-8.30%24.73M
10.73%115.38M
28.52%31.21M
3.15%27.44M
11.96%29.77M
Depreciation amortization depletion
1.94%3.78M
-29.76%14.95M
1.43%3.77M
-0.85%3.73M
1.27%3.75M
-63.35%3.7M
72.03%21.29M
22.45%3.72M
17.21%3.76M
22.50%3.71M
-Depreciation and amortization
1.94%3.78M
-29.76%14.95M
1.43%3.77M
-0.85%3.73M
1.27%3.75M
-63.35%3.7M
72.03%21.29M
22.45%3.72M
17.21%3.76M
22.50%3.71M
Operating profit
174.01%11.47M
-36.66%18M
-35.33%23.04M
244.31%11.76M
56.78%-1.31M
-490.94%-15.5M
-74.53%28.41M
-1.17%35.63M
-130.65%-8.15M
-124.22%-3.03M
Net non-operating interest income expense
-27.54%-18.36M
-33.98%-67.78M
-37.04%-19.31M
-23.87%-17.74M
-20.15%-16.33M
-67.70%-14.4M
-48.04%-50.59M
-53.13%-14.09M
-69.41%-14.32M
-59.45%-13.59M
Non-operating interest income
-7.10%4.11M
-7.81%18.47M
-10.85%4.36M
-1.33%4.98M
-6.88%4.71M
-12.30%4.42M
16.50%20.04M
7.56%4.89M
9.59%5.05M
28.41%5.06M
Non-operating interest expense
19.40%22.47M
22.12%86.26M
24.70%23.67M
17.30%22.73M
12.82%21.04M
38.10%18.82M
37.48%70.63M
38.06%18.98M
48.32%19.37M
49.64%18.65M
Other net income (expense)
3,211.11%4.48M
-13,125.25%-513.72M
-42.19%581K
-139.87%-842K
-35,821.02%-513.31M
76.39%-144K
6.08%3.94M
-50.07%1.01M
348.41%2.11M
1,027.10%1.44M
Special income (charges)
----
---511.37M
--0
--0
---511.37M
----
--0
--0
--0
--0
-Less:Impairment of capital assets
----
--511.37M
--0
--0
--511.37M
----
--0
--0
--0
--0
-Gain on sale of business
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
3,211.11%4.48M
-159.61%-2.35M
-42.19%581K
-139.87%-842K
-235.42%-1.95M
76.39%-144K
6.08%3.94M
-50.07%1.01M
348.41%2.11M
1,027.10%1.44M
Income before tax
91.98%-2.41M
-2,989.88%-563.5M
-80.88%4.31M
66.49%-6.82M
-3,396.56%-530.95M
-474.30%-30.04M
-122.50%-18.24M
-21.89%22.54M
-209.42%-20.36M
-497.10%-15.19M
Income tax
146.55%2.21M
-316.43%-47.03M
93.63%6.01M
85.31%-1.42M
-1,584.48%-46.88M
-143.36%-4.74M
-184.73%-11.29M
-65.58%3.11M
-988.63%-9.67M
-673.06%-2.78M
Net income
81.75%-4.62M
-7,337.70%-516.47M
-108.77%-1.7M
49.47%-5.4M
-3,803.18%-484.07M
-670.89%-25.29M
-110.25%-6.94M
-2.01%19.44M
-154.85%-10.7M
-396.41%-12.4M
Net income continuous Operations
81.75%-4.62M
-7,337.70%-516.47M
-108.77%-1.7M
49.47%-5.4M
-3,803.18%-484.07M
-670.89%-25.29M
-110.25%-6.94M
-2.01%19.44M
-154.85%-10.7M
-396.41%-12.4M
Minority interest income
Net income attributable to the parent company
81.75%-4.62M
-7,337.70%-516.47M
-108.77%-1.7M
49.47%-5.4M
-3,803.18%-484.07M
-670.89%-25.29M
-110.25%-6.94M
-2.01%19.44M
-154.85%-10.7M
-396.41%-12.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
81.75%-4.62M
-7,337.70%-516.47M
-108.77%-1.7M
49.47%-5.4M
-3,803.18%-484.07M
-670.89%-25.29M
-110.25%-6.94M
-2.01%19.44M
-154.85%-10.7M
-396.41%-12.4M
Basic earnings per share
81.82%-0.06
-7,388.89%-6.74
-108.69%-0.0219
50.00%-0.07
-3,843.75%-6.31
-725.00%-0.33
-110.59%-0.09
-0.74%0.2519
-158.33%-0.14
-420.00%-0.16
Diluted earnings per share
81.82%-0.06
-7,388.89%-6.74
-108.75%-0.0219
50.00%-0.07
-3,843.75%-6.31
-725.00%-0.33
-110.71%-0.09
0.00%0.25
-158.33%-0.14
-420.00%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 2.42%391.92M1.53%1.64B-1.74%434.93M5.57%402.06M-0.61%415.61M3.74%382.65M4.47%1.61B11.49%442.65M-0.41%380.83M9.68%418.18M
Operating revenue 2.42%391.92M1.53%1.64B-1.74%434.93M5.57%402.06M-0.61%415.61M3.74%382.65M4.47%1.61B11.49%442.65M-0.41%380.83M9.68%418.18M
Cost of revenue -7.06%174.94M10.32%803.63M10.58%214.06M8.02%195.07M7.29%206.27M16.16%188.22M10.90%728.47M13.50%193.57M10.07%180.6M10.34%192.26M
Gross profit 11.60%216.98M-5.72%831.62M-11.32%220.87M3.37%206.99M-7.34%209.33M-6.00%194.43M-0.30%882.06M9.97%249.07M-8.29%200.24M9.12%225.92M
Operating expense -2.10%205.51M-4.69%813.63M-7.32%197.83M-6.31%195.23M-8.00%210.64M3.48%209.93M10.40%853.65M12.08%213.45M8.68%208.39M17.70%228.95M
Selling and administrative expenses -1.80%178.24M-2.41%699.7M-5.18%169.27M-4.60%169.05M-7.97%179.89M9.47%181.5M9.19%716.98M9.44%178.52M9.41%177.19M18.53%195.47M
Research and development costs -4.96%23.5M-14.22%98.97M-20.57%24.79M-18.15%22.46M-9.31%27M-8.30%24.73M10.73%115.38M28.52%31.21M3.15%27.44M11.96%29.77M
Depreciation amortization depletion 1.94%3.78M-29.76%14.95M1.43%3.77M-0.85%3.73M1.27%3.75M-63.35%3.7M72.03%21.29M22.45%3.72M17.21%3.76M22.50%3.71M
-Depreciation and amortization 1.94%3.78M-29.76%14.95M1.43%3.77M-0.85%3.73M1.27%3.75M-63.35%3.7M72.03%21.29M22.45%3.72M17.21%3.76M22.50%3.71M
Operating profit 174.01%11.47M-36.66%18M-35.33%23.04M244.31%11.76M56.78%-1.31M-490.94%-15.5M-74.53%28.41M-1.17%35.63M-130.65%-8.15M-124.22%-3.03M
Net non-operating interest income expense -27.54%-18.36M-33.98%-67.78M-37.04%-19.31M-23.87%-17.74M-20.15%-16.33M-67.70%-14.4M-48.04%-50.59M-53.13%-14.09M-69.41%-14.32M-59.45%-13.59M
Non-operating interest income -7.10%4.11M-7.81%18.47M-10.85%4.36M-1.33%4.98M-6.88%4.71M-12.30%4.42M16.50%20.04M7.56%4.89M9.59%5.05M28.41%5.06M
Non-operating interest expense 19.40%22.47M22.12%86.26M24.70%23.67M17.30%22.73M12.82%21.04M38.10%18.82M37.48%70.63M38.06%18.98M48.32%19.37M49.64%18.65M
Other net income (expense) 3,211.11%4.48M-13,125.25%-513.72M-42.19%581K-139.87%-842K-35,821.02%-513.31M76.39%-144K6.08%3.94M-50.07%1.01M348.41%2.11M1,027.10%1.44M
Special income (charges) -------511.37M--0--0---511.37M------0--0--0--0
-Less:Impairment of capital assets ------511.37M--0--0--511.37M------0--0--0--0
-Gain on sale of business --------------------------0------------
Other non- operating income (expenses) 3,211.11%4.48M-159.61%-2.35M-42.19%581K-139.87%-842K-235.42%-1.95M76.39%-144K6.08%3.94M-50.07%1.01M348.41%2.11M1,027.10%1.44M
Income before tax 91.98%-2.41M-2,989.88%-563.5M-80.88%4.31M66.49%-6.82M-3,396.56%-530.95M-474.30%-30.04M-122.50%-18.24M-21.89%22.54M-209.42%-20.36M-497.10%-15.19M
Income tax 146.55%2.21M-316.43%-47.03M93.63%6.01M85.31%-1.42M-1,584.48%-46.88M-143.36%-4.74M-184.73%-11.29M-65.58%3.11M-988.63%-9.67M-673.06%-2.78M
Net income 81.75%-4.62M-7,337.70%-516.47M-108.77%-1.7M49.47%-5.4M-3,803.18%-484.07M-670.89%-25.29M-110.25%-6.94M-2.01%19.44M-154.85%-10.7M-396.41%-12.4M
Net income continuous Operations 81.75%-4.62M-7,337.70%-516.47M-108.77%-1.7M49.47%-5.4M-3,803.18%-484.07M-670.89%-25.29M-110.25%-6.94M-2.01%19.44M-154.85%-10.7M-396.41%-12.4M
Minority interest income
Net income attributable to the parent company 81.75%-4.62M-7,337.70%-516.47M-108.77%-1.7M49.47%-5.4M-3,803.18%-484.07M-670.89%-25.29M-110.25%-6.94M-2.01%19.44M-154.85%-10.7M-396.41%-12.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 81.75%-4.62M-7,337.70%-516.47M-108.77%-1.7M49.47%-5.4M-3,803.18%-484.07M-670.89%-25.29M-110.25%-6.94M-2.01%19.44M-154.85%-10.7M-396.41%-12.4M
Basic earnings per share 81.82%-0.06-7,388.89%-6.74-108.69%-0.021950.00%-0.07-3,843.75%-6.31-725.00%-0.33-110.59%-0.09-0.74%0.2519-158.33%-0.14-420.00%-0.16
Diluted earnings per share 81.82%-0.06-7,388.89%-6.74-108.75%-0.021950.00%-0.07-3,843.75%-6.31-725.00%-0.33-110.71%-0.090.00%0.25-158.33%-0.14-420.00%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More